Cargando…

Adaptive evolution of peptide inhibitors for mutating SARS-CoV-2

Mostrar otras versiones (1)

The SARS-CoV-2 virus is currently causing a worldwide pandemic with dramatic societal consequences for the humankind. In the last decades, disease outbreaks due to such zoonotic pathogens have appeared with an accelerated rate, which calls for an urgent development of adaptive (smart) therapeutics....

Descripción completa

Detalles Bibliográficos
Autores principales:	Chaturvedi, Parth, Han, Yanxiao, Král, Petr, Vuković, Lela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	ChemRxiv 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359527/ https://www.ncbi.nlm.nih.gov/pubmed/32676578 http://dx.doi.org/10.26434/chemrxiv.12622667

Ejemplares similares

Adaptive Evolution of Peptide Inhibitors for Mutating SARS-CoV-2
por: Chaturvedi, Parth, et al.
Publicado: (2021)

Computational screening of nanoparticles coupling to Aβ40 peptides and fibrils
por: Sen, Soumyo, et al.
Publicado: (2019)

Photochemical control of bacterial gene expression based on trans encoded genetic switches
por: Paul, Avishek, et al.
Publicado: (2021)

Evolution of the SARS-CoV-2 mutational spectrum
por: Bloom, Jesse D, et al.
Publicado: (2022)

Evolution of the SARS-CoV-2 Mutational Spectrum
por: Bloom, Jesse D, et al.
Publicado: (2023)

Peptide and peptide-based inhibitors of SARS-CoV-2 entry
por: Schütz, Desiree, et al.
Publicado: (2020)

Mutations and Evolution of the SARS-CoV-2 Spike Protein
por: Magazine, Nicholas, et al.
Publicado: (2022)

The Yin and Yang of SARS-CoV-2 Mutation and Evolution
por: Badley, Andrew D.
Publicado: (2021)

Detecting Potentially Adaptive Mutations from the Parallel and Fixed Patterns in SARS-CoV-2 Evolution
por: Ji, Cheng-Yang, et al.
Publicado: (2022)

Ongoing Global and Regional Adaptive Evolution of SARS-CoV-2
por: Rochman, Nash D., et al.
Publicado: (2021)

Ongoing global and regional adaptive evolution of SARS-CoV-2
por: Rochman, Nash D., et al.
Publicado: (2021)

Attenuation and Degeneration of SARS-CoV-2 Despite Adaptive Evolution
por: Liu, Yingguang
Publicado: (2023)

Contributions of adaptation and purifying selection to SARS-CoV-2 evolution
por: Neher, Richard A
Publicado: (2022)

Synonymous mutations and the molecular evolution of SARS-CoV-2 origins
por: Wang, Hongru, et al.
Publicado: (2020)

Analysis of Continuous Mutation and Evolution on Circulating SARS-CoV-2
por: Yu, Jie-Mei, et al.
Publicado: (2020)

T-CoV: a comprehensive portal of HLA-peptide interactions affected by SARS-CoV-2 mutations
por: Nersisyan, Stepan, et al.
Publicado: (2021)

Mutation rate of SARS-CoV-2 and emergence of mutators during experimental evolution
por: Amicone, Massimo, et al.
Publicado: (2022)

Adaptive Evolution of SARS-CoV-2: A Perspective from Dynamics
por: Kazan, Ismail C., et al.
Publicado: (2021)

Drivers of adaptive evolution during chronic SARS-CoV-2 infections
por: Harari, Sheri, et al.
Publicado: (2022)

Scalable Inhibitors of the Nsp3–Nsp4 Coupling in SARS-CoV-2
por: Azizogli, Abdul-Rahman, et al.
Publicado: (2023)

Natural heteroclitic-like peptides are generated by SARS-CoV-2 mutations
por: Tiezzi, Camilla, et al.
Publicado: (2023)

A cyclic peptide inhibitor of the SARS-CoV-2 main protease
por: Kreutzer, Adam G., et al.
Publicado: (2021)

RdRp mutations are associated with SARS-CoV-2 genome evolution
por: Eskier, Doğa, et al.
Publicado: (2020)

Evolution of SARS-CoV-2 mutational variants: Hysteria or hope for the future?
por: Esmail, A, et al.
Publicado: (2021)

Peptide Targets to SARS-CoV-2
por: Mandal, Santi M.
Publicado: (2020)

The evolution of the mechanisms of SARS-CoV-2 evolution revealing vaccine-resistant mutations in Europe and America
por: Wang, Rui, et al.
Publicado: (2021)

Evolution and Variation of the SARS-CoV Genome
por: Hu, Jianfei, et al.
Publicado: (2003)

On the origin and evolution of SARS-CoV-2
por: Singh, Devika, et al.
Publicado: (2021)

Origin and evolution of SARS-CoV-2
por: Pagani, Isabel, et al.
Publicado: (2023)

Computational designing of a peptide that potentially blocks the entry of SARS-CoV, SARS-CoV-2 and MERS-CoV
por: V. K., Priya, et al.
Publicado: (2021)

Bionics design of affinity peptide inhibitors for SARS-CoV-2 RBD to block SARS-CoV-2 RBD-ACE2 interactions
por: Liu, Xiaofeng, et al.
Publicado: (2023)

Adaptive immunity to SARS-CoV-2
por: Altmann, Daniel M
Publicado: (2020)

The adaptation of SARS-CoV-2 to humans
por: Tosta, Eduardo
Publicado: (2022)

Mutational cascade of SARS-CoV-2 leading to evolution and emergence of omicron variant
por: Bansal, Kanika, et al.
Publicado: (2022)

Origin and Reversion of Omicron Core Mutations in the Evolution of SARS-CoV-2 Genomes
por: Zhao, Xinwei, et al.
Publicado: (2022)

Peptide-based pan-CoV fusion inhibitors maintain high potency against SARS-CoV-2 Omicron variant
por: Xia, Shuai, et al.
Publicado: (2022)

Large-scale analysis of SARS-CoV-2 synonymous mutations reveals the adaptation to the human codon usage during the virus evolution
por: Ramazzotti, Daniele, et al.
Publicado: (2022)

Immunoreactive peptide maps of SARS-CoV-2
por: Mishra, Nischay, et al.
Publicado: (2021)

Hotspot Mutations in SARS-CoV-2
por: Saha, Indrajit, et al.
Publicado: (2021)

The Mutational Landscape of SARS-CoV-2
por: Saldivar-Espinoza, Bryan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1ko1c1obamfr3tr0138lltsfe3